Literature DB >> 18319519

Adverse outcomes in fibrinolytic-based facilitated percutaneous coronary intervention: insights from the ASSENT-4 PCI electrocardiographic substudy.

Michael A McDonald1, Yuling Fu, Uwe Zeymer, Galen Wagner, Shaun G Goodman, Allan Ross, Christopher B Granger, Frans Van de Werf, Paul W Armstrong.   

Abstract

AIMS: Patients in ASSENT-4 PCI undergoing tenecteplase-facilitated percutaneous coronary intervention (PCI) had more adverse events than those undergoing primary PCI. We analysed this to gain further insights. METHODS AND
RESULTS: A total of 549 patients with facilitated PCI and 541 undergoing primary PCI were characterized according to the extent of ST resolution. We also examined the relationship between time from symptom onset, presence of baseline Q waves, and 90 day events. Irrespective of treatment, 90 day mortality was lowest among 186 patients with complete ST resolution at both 60 and 180 min (1.8% facilitated; 0% primary PCI group) and highest in those 502 patients without complete ST resolution at either 60 or 180 min (6.7% facilitated; 5.2% primary PCI group, all P < or = 0.05). Patients undergoing facilitated PCI presenting >3 h with baseline Q waves also had higher 90 day mortality compared with those without Q waves (10.4 vs. 2.5%, P = 0.056). No significant differences were found within primary PCI patients on the basis of time from symptom onset or presence of initial Q waves.
CONCLUSION: In this post hoc analysis, our data suggest that a fibrinolysis-facilitated PCI strategy was especially harmful in patients presenting beyond 3 h from symptom onset with established Q waves on their baseline ECG. This may relate to the convergence of later, less effective pre-procedural reperfusion but persisting exposure to the pro-thrombotic and bleeding risks of fibrinolysis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18319519     DOI: 10.1093/eurheartj/ehn078

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  3 in total

Review 1.  ST-segment resolution and prognosis after facilitated versus primary percutaneous coronary intervention in acute myocardial infarction: a meta-analysis.

Authors:  Ingo Eitel; Annegret Franke; Gerhard Schuler; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2009-08-29       Impact factor: 5.460

2.  ST segment resolution in patients with tenecteplase-facilitated percutaneous coronary intervention versus tenecteplase alone: Insights from the Combined Angioplasty and Pharmacological Intervention versus Thrombolysis ALone in Acute Myocardial Infarction (CAPITAL AMI) trial.

Authors:  D Y So; A C Ha; R F Davies; M Froeschl; G A Wells; M R Le May
Journal:  Can J Cardiol       Date:  2010-01       Impact factor: 5.223

3.  The effects of tirofiban infusion on clinical and angiographic outcomes of patients with STEMI undergoing primary PCI.

Authors:  Cihangir Kaymaz; Nurşen Keleş; Nihal Özdemir; İbrahim Halil Tanboğa; Hacer C Demircan; Mehmet M Can; Fatih Koca; İbrahim Akın İzgi; Alper Özkan; Muhsin Türkmen; Cevat Kırma; Ali M Esen
Journal:  Anatol J Cardiol       Date:  2014-12-25       Impact factor: 1.596

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.